Protagen and Geneva Bioinformatics (GeneBio) have signed a distribution agreement that allows GeneBio to distribute Protagen’s Modiro, a software tool enabling rapid and automated detection of true post-translational modifications in MS/MS datasets.
Under the terms of the agreement, GeneBio will distribute the Modiro package on a global basis; at the same time, GeneBio and Protagen will collaborate to link the Modiro functionalities to GeneBio’s Phenyx software platform for MS data analysis.
Post-translational protein modifications modulate the activity of many proteins and the in-depth analysis of these changes is of growing importance in the research and development of new drug candidates. Modiro enables researchers to identify significantly more of these crucial modifications using existing mass-spectrometry data. In addition, the automated identification of PTMs by Modiro significantly reduces time and efforts in protein analyses.
Developed in collaboration with the Swiss Institute of Bioinformatics (SIB), Phenyx is GeneBio’s software platform for the identification and characterisation of proteins and peptides from mass spectrometry data. The Phenyx platform is specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment via a customisable architecture and an innovative user friendly interface.
